Cofetuzumab (Anti-PTK7 / CCK4)
Cofetuzumab (Anti-PTK7 / CCK4) is humanized IgG1 monoclonal antibody against protein tyrosine kinase 7 (PTK7) with potential antitumor activity. MW : 146.7 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2803 |
| Sku # | A2803-1mg*25 |
| Pricing | 1mg*25, $5070.00 |